Celadon Pharma

News

Celadon Pharmaceuticals has secured the final approval needed to start a large-scale trial of its cannabinoid therapy for chronic pain in the UK.

Oncology

At ASCO 2026, BI Global Head of Oncology Itziar Canamasas spoke with pharmaphorum about the company's ASCO data and broader oncology strategy.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.